DOCSLIB.ORG

Risk Assessment of Herbal Preparations Containing St John's Wort

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Risk Assessment of Herbal Preparations Containing St John's Wort National Institute forPublic Health and the Environment Ministryof Health, Welfare and Sport Risk assessment of herbal preparations containing St John’s wort RIVM report 2019-0115 L. de Wit | S. Jeurissen | W. Chen Risk assessment of herbal preparations containing St John's wort RIVM report 2019-0115 RIVM report 2019-0115 Colophon © RIVM 2021 Parts of this publication may be reproduced, provided acknowledgement is given to the: National Institute for Public Health and the Environment, and the title and year of publication are cited. DOI 10.21945/RIVM-2019-0115 L. de Wit (author), RIVM S. Jeurissen (author), RIVM W. Chen (author), RIVM Contact: Lianne de Wit Voeding, Preventie en Zorg\Voedselveiligheid [email protected] This investigation was performed by order, and for the account, of Ministry of Health, Welfare and Sport, within the framework of project 5.1.15. Published by: National Institute for Public Health and the Environment, RIVM P.O. Box 1 | 3720 BA Bilthoven The Netherlands www.rivm.nl/en Page 2 of 148 RIVM report 2019-0115 Synopsis Risk assessment of herbal preparations containing St John's wort People use herbal preparations (food supplements and herbal tea) with St John’s wort, amongst others to feel and sleep better. However, these herbal preparations can reduce the effect of medicines, or enhance their effect. These interactions can have serious health effects. Herbal preparations with St John’s wort, for example, reduce the effect of certain medicines prescribed for fungal or viral infections and for cancer (chemotherapy). The effect of certain consciousness-lowering agents, e.g. sedative medicines, and consciousness-stimulating agents, e.g. antidepressants, is actually enhanced. The use of herbal preparations with St John’s wort may also pose health risks when used alone and not in combination with medicines. For example, the skin can be damaged faster (sunburn) if people sit in the sun after using St John’s wort. Other effects such as dizziness, diarrhea and anxiety have also been reported after the use of herbal preparations containing St. John's wort. It is not known what effects occur after people use these herbal preparations for a long time. There is also insufficient information available to determine whether the use of St John’s wort during pregnancy is safe for the unborn child. Moreover, the composition of herbal preparations containing St John’s wort can vary greatly, and it is often not known what exactly is in it. This makes it difficult to estimate the effects of a product. RIVM draws these conclusions based on a risk assessment on behalf of the Ministry of Health, Welfare and Sport (VWS). RIVM advises consumers to be cautious with the use of herbal preparations containing St John’s wort, and to not use these products in combination with medicines. RIVM advises VWS to draft legislation on the use of St John’s wort in herbal preparations. Keywords: Hypericum perforatum, dietary supplement, botanical, hypericin, hyperforin, herbal preparation Page 3 of 148 RIVM report 2019-0115 Page 4 of 148 RIVM report 2019-0115 Publiekssamenvatting Risicobeoordeling van kruidenpreparaten met sint-janskruid Mensen gebruiken kruidenpreparaten (voedingssupplementen en kruidenthee) met sint-janskruid onder andere om zich beter te voelen en beter te kunnen slapen. Maar deze kruidenpreparaten kunnen de werking van geneesmiddelen verminderen, of juist versterken. Deze wisselwerkingen kunnen ernstige gezondheidseffecten hebben. Kruidenpreparaten met sint-janskruid verminderen bijvoorbeeld de werking van middelen die worden voorgeschreven bij schimmel- of virusinfecties en bij chemotherapie. De werking van bepaalde bewustzijns-verlagende geneesmiddelen, zoals kalmeringsmiddelen, en bewustzijns-stimulerende middelen, bijvoorbeeld antidepressiva, wordt versterkt. Ook zonder de combinatie met geneesmiddelen kan het gebruik van kruidenpreparaten met sint-janskruid schadelijk zijn voor de gezondheid. Zo kan de huid sneller beschadigd raken (zonnebrand) als mensen na het gebruik van sint-janskruid in de zon gaan zitten. Ook worden andere effecten zoals duizeligheid, diarree en angst gemeld na het gebruik van kruidenpreparaten met sint-janskruid. Het is niet bekend welke effecten optreden als mensen deze kruidenpreparaten lang gebruiken. Ook is er onvoldoende informatie om te bepalen of het gebruik van sint-janskruid tijdens de zwangerschap veilig is voor het ongeboren kind. Bovendien verschilt de samenstelling van kruidenpreparaten met sint-janskruid sterk en is vaak niet bekend wat er precies in zit. Dit maakt het moeilijk om de effecten van een product in te schatten. Deze conclusies trekt het RIVM op basis van een risicobeoordeling, in opdracht van VWS. Het RIVM adviseert consumenten om voorzichtig te zijn met het gebruik van kruidenpreparaten met sint-janskruid omdat deze schadelijk kunnen zijn voor de gezondheid. Daarom raadt het RIVM VWS aan om regelgeving over het gebruik van sint-janskruid in kruidenpreparaten op te stellen. Kernwoorden: Hypericum perforatum, voedingssupplement, kruidenpreparaat, hypericine, hyperforine Page 5 of 148 RIVM report 2019-0115 Page 6 of 148 RIVM report 2019-0115 Contents Summary — 9 1 Introduction — 15 1.1 Background — 15 1.2 Information on existing assessments — 15 Scientific Committee on Food — 15 European Medicines Agency — 16 RIVM — 17 1.3 Information on existing legislation — 17 1.4 Reading guide — 18 2 Methodology — 19 3 Identification and characterization — 21 3.1 Identity and nature of the source material — 21 3.2 Manufacturing process — 21 3.3 Chemical composition — 22 3.4 Stability — 25 3.5 Uses and use levels — 25 4 Exposure: extent and duration — 29 4.1 Exposure from food supplements — 29 4.2 Possibility of additional human exposure — 29 5 Biological data — 31 5.1 Introduction — 31 5.2 Toxicokinetics — 31 Absorption — 31 Distribution — 42 Biotransformation — 44 Excretion — 45 Effects on enzymes — 48 Summary on toxicokinetics — 50 5.3 Toxicological studies — 51 Acute toxicity — 51 Short-term and sub-chronic toxicity — 54 Genotoxicity — 56 Chronic toxicity and carcinogenicity — 64 Reproductive and developmental toxicity — 64 Phototoxicity — 70 Human information — 76 Interactions — 81 Summary on toxicological information — 82 5.4 Derivation of toxicological reference value — 85 6 Risk assessment — 87 6.1 Risk assessment — 87 6.2 Sensitive/vulnerable groups — 88 6.3 Uncertainties — 88 Exposure — 88 Page 7 of 148 RIVM report 2019-0115 Toxicity — 88 7 Conclusion and recommendations — 89 Acknowledgements — 91 References — 93 Annex 1 Search strategy St John’s wort — 105 Annex 2 Intake assessment of St John’s wort via plant food supplements — 107 Annex 3 Case studies — 112 Annex 4 Clinical trials — 126 Page 8 of 148 RIVM report 2019-0115 Summary Introduction St John’s wort (Hypericum perforatum L.) is used in food supplements and herbal teas (herbal preparations) that are marketed as mood enhancers and sleep aids, among other things. Hypericin, pseudohypericin and hyperforin are generally thought to be the most relevant constituents for the pharmacological effects of St John’s wort (Linde, 2009). St John’s wort can cause interactions with several prescribed medicines, as described in a previous RIVM report (Tiesjema et al., 2013). These interactions can have serious health effects. Herbal preparations with St John’s wort, for example, reduce the effect of some medicines prescribed for fungal or viral infections and for cancer (chemotherapy). They also reduce the effect of several medicines that suppress the immune system, and are used with tissue transplants. The effect of certain antidepressants (selective serotonin reuptake inhibitors, SSRIs) may be enhanced, which could result in serotonin syndrome. Other aspects of the safety of herbal preparations containing St John’s wort were not addressed in that report. Currently, there are no specific restrictions for the use of St John’s wort in herbal preparations included in the Herbal Preparations Decree of the Dutch Commodities Act. However, a warning on all products containing St John’s wort about possible interactions with medicines will be made a legal requirement.1 The Ministry of Health, Welfare and Sport (VWS) asked RIVM to perform a risk assessment on the safety of herbal preparations containing St John’s wort to investigate whether other restrictions on the use of St John’s wort in herbal preparations are needed besides warning phrases about interactions with medicines. Use of St John’s wort as a herbal medicine St John’s wort is also used in registered herbal medicines to treat mild to moderate depression (Dutch Medicines Evaluation Board (MEB), 2020). Two medicinal products containing St John’s wort are registered in the Netherlands (reference date July 2020). However, only one is still available on the market and can be bought over the counter in pharmacies. This medicinal product has a recommended daily dose of 132 mg dried ethanol (68% v/v) extract, equivalent to 850 – 2600 mg fresh plant. Assuming that the extract contains 0.1 – 0.3% hypericins, this is equivalent to a daily dose of approximately 0.13 – 0.40 mg hypericins per day. In addition, 30 homeopathic products containing St. John’s wort are registered in the Netherlands. Of the homeopathic medicines, 7 contain H. perforatum L. as the only active ingredient and the others contain one or more other active ingredients in addition to St. John’s wort (MEB, 2020). St John’s wort products currently have a dual 1 https://www.rijksoverheid.nl/documenten/kamerstukken/2018/02/12/beantwoording-kamervragen-over-de-
Load more

Recommended publications
  • Determining the True Content of Quercetin and Its Derivatives in Plants Employing SSDM and LC–MS Analysis
    Eur Food Res Technol (2017) 243:27–40 DOI 10.1007/s00217-016-2719-8 ORIGINAL PAPER Determining the true content of quercetin and its derivatives in plants employing SSDM and LC–MS analysis Dorota Wianowska1 · Andrzej L. Dawidowicz1 · Katarzyna Bernacik1 · Rafał Typek1 Received: 31 March 2016 / Revised: 4 May 2016 / Accepted: 19 May 2016 / Published online: 1 June 2016 © The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Reliable plant analysis is a challenging task due Introduction to the physical character and chemical complexity of plant matrices. First of all, it requires the application of a proper Quercetin is one of the most widely distributed polyphe- sample preparation procedure to fully isolate the analyzed nolics in plants. This aglycone compound occurs in fruits, substances from the plant matrix. The high-temperature vegetables, leaves and grains, often in the form of glycoside liquid–solid extraction is commonly applied for this pur- derivatives. Rutin (quercetin-3-O-rutinoside), isoquercitrin pose. In the light of recently published results, however, (quercetin-3-O-glucoside) and quercitrin (quercetin-3-O- the application of high-temperature extraction for poly- rhamnoside) are the most ubiquitous quercetin glycosides phenolics analysis in plants is disputable as it causes their [1]. In view of the antioxidant, anti-inflammatory and anti- transformation leading to erroneous quantitative estima- cancer properties of quercetin and its glycosides, research tions of these compounds. Experiments performed on dif- interest in the natural occurrence and medical properties of ferent plants show that the transformation/degradation of these compounds has been growing [2–4].
    [Show full text]
  • Globalisation of Herbal Drugs: a Bliss and Concern
    International Journal of Science and Research (IJSR) ISSN (Online): 2319-7064 Impact Factor (2012): 3.358 Globalisation of Herbal Drugs: A Bliss and Concern Jyoti Ahlawat1, Nidhi Verma2, Anita R. Sehrawat3 1, 2, 3Department of Botany, M. D. University, Rohtak, India Abstract: A “man earth relationship” has been well canvassed to encourage the usage of botanicals. The use of plants for healing purposes predates to the Neanderthal period in human history and forms the origin of much modern medicine. 25% of drugs prescribed worldwide come from plants. India has about 45000 plant species out of which 15,000-20,000 have active principles of proven medicinal values. India ranks second in the world in herbal medicine and there is enormous scope to emerge as a major player. Natural plant products are perceived to be healthier than manufactured medicine Herbal medicines are now in great demand in the developing world for primary health care not because they are inexpensive but also for better cultural acceptability, better compatibility with the human body and minimal side effects. However recent findings indicate that traditional herbal products are heterogeneous in nature and may not be safe and impose a number of challenges to qualify control, quality assurance, effectiveness and the regulatory process. Some products contain mercury, lead, arsenic and corticosteroids and poisonous organic substances in harmful amount. Hepatic failure and even death following ingestion of herbal medicine have been reported. Medicinal plant materials and possibly herbal tea, if stored improperly allow the growth of Aspergillus flavus a known producer of aflotoxin mycotoxin. Herbal preparation should be used with extreme caution on the advice of a herbalist familiar with the relevant conventional pharmacology.
    [Show full text]
  • Phytochemical Composition and Biological Activities of Scorzonera Species
    International Journal of Molecular Sciences Review Phytochemical Composition and Biological Activities of Scorzonera Species Karolina Lendzion 1 , Agnieszka Gornowicz 1,* , Krzysztof Bielawski 2 and Anna Bielawska 1 1 Department of Biotechnology, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland; [email protected] (K.L.); [email protected] (A.B.) 2 Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-85-748-5742 Abstract: The genus Scorzonera comprises nearly 200 species, naturally occurring in Europe, Asia, and northern parts of Africa. Plants belonging to the Scorzonera genus have been a significant part of folk medicine in Asia, especially China, Mongolia, and Turkey for centuries. Therefore, they have become the subject of research regarding their phytochemical composition and biological activity. The aim of this review is to present and assess the phytochemical composition, and bioactive potential of species within the genus Scorzonera. Studies have shown the presence of many bioactive compounds like triterpenoids, sesquiterpenoids, flavonoids, or caffeic acid and quinic acid derivatives in extracts obtained from aerial and subaerial parts of the plants. The antioxidant and cytotoxic properties have been evaluated, together with the mechanism of anti-inflammatory, analgesic, and hepatoprotective activity. Scorzonera species have also been investigated for their activity against several bacteria and fungi strains. Despite mild cytotoxicity against cancer cell lines in vitro, the bioactive properties in wound healing therapy and the treatment of microbial infections might, in perspective, be the starting point for the research on Scorzonera species as active agents in medical products designed for Citation: Lendzion, K.; Gornowicz, miscellaneous skin conditions.
    [Show full text]
  • Determining the True Content of Quercetin and Its Derivatives in Plants Employing SSDM and LC–MS Analysis
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Eur Food Res Technol (2017) 243:27–40 DOI 10.1007/s00217-016-2719-8 ORIGINAL PAPER Determining the true content of quercetin and its derivatives in plants employing SSDM and LC–MS analysis Dorota Wianowska1 · Andrzej L. Dawidowicz1 · Katarzyna Bernacik1 · Rafał Typek1 Received: 31 March 2016 / Revised: 4 May 2016 / Accepted: 19 May 2016 / Published online: 1 June 2016 © The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Reliable plant analysis is a challenging task due Introduction to the physical character and chemical complexity of plant matrices. First of all, it requires the application of a proper Quercetin is one of the most widely distributed polyphe- sample preparation procedure to fully isolate the analyzed nolics in plants. This aglycone compound occurs in fruits, substances from the plant matrix. The high-temperature vegetables, leaves and grains, often in the form of glycoside liquid–solid extraction is commonly applied for this pur- derivatives. Rutin (quercetin-3-O-rutinoside), isoquercitrin pose. In the light of recently published results, however, (quercetin-3-O-glucoside) and quercitrin (quercetin-3-O- the application of high-temperature extraction for poly- rhamnoside) are the most ubiquitous quercetin glycosides phenolics analysis in plants is disputable as it causes their [1]. In view of the antioxidant, anti-inflammatory and anti- transformation leading to erroneous quantitative estima- cancer properties of quercetin and its glycosides, research tions of these compounds. Experiments performed on dif- interest in the natural occurrence and medical properties of ferent plants show that the transformation/degradation of these compounds has been growing [2–4].
    [Show full text]
  • A Comparative Bio-Evaluation and Chemical Profiles of Calendula
    applied sciences Article A Comparative Bio-Evaluation and Chemical Profiles of Calendula officinalis L. Extracts Prepared via Different Extraction Techniques Gunes Ak 1, Gokhan Zengin 1 , Kouadio Ibrahime Sinan 1, Mohamad Fawzi Mahomoodally 2,3,*, Marie Carene Nancy Picot-Allain 3 , Oguz Cakır 4 , Souheir Bensari 5, Mustafa Abdullah Yılmaz 6 , Monica Gallo 7,* and Domenico Montesano 8 1 Department of Biology, Science Faculty, Selcuk University, 42130 Konya, Turkey; [email protected] (G.A.); [email protected] (G.Z.); [email protected] (K.I.S.) 2 Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam 3 Department of Health Sciences, Faculty of Science, University of Mauritius, 230 Réduit, Mauritius; [email protected] 4 Science and Technology Research and Application Center, Dicle University, 21280 Diyarbakir, Turkey; [email protected] 5 Laboratoire de Génétique, Biochimie et Biotechnologies Végétales GBBV, Faculté des Sciences de la Nature et de la Vie, Université Frères Mentouri Constantine1, Route d’Aïn El Bey, 25017 Constantine, Algeria; [email protected] 6 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Dicle University, 21280 Diyarbakir, Turkey; [email protected] 7 Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, via Pansini, 5, 80131 Naples, Italy 8 Department of Pharmaceutical Sciences, Section of Food Science and Nutrition, University of Perugia, via San Costanzo 1, 06126 Perugia, Italy; [email protected] * Correspondence: [email protected] (M.F.M.); [email protected] (M.G.) Received: 19 July 2020; Accepted: 24 August 2020; Published: 26 August 2020 Featured Application: This study provides valuable data on the influence of extraction techniques on the recovery of bioactive compounds from Calendula officinalis useful for the formulation of therapeutic preparations.
    [Show full text]
  • Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed)
    Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed) Authors: Igor A. Schepetkin, Andrew G. Ramstead, Liliya N. Kirpotina, Jovanka M. Voyich, Mark A. Jutila, and Mark T. Quinn This is the peer reviewed version of the following article: [Schepetkin, IA, AG Ramstead, LN Kirpotina, JM Voyich, MA Jutila, and MT Quinn. "Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed)." Phytotherapy Research 30, no. 8 (May 2016): 1287-1297.], which has been published in final form at https://dx.doi.org/10.1002/ptr.5648. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Made available through Montana State University’s ScholarWorks scholarworks.montana.edu Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed) Igor A. Schepetkin, Andrew G. Ramstead, Liliya N. Kirpotina, Jovanka M. Voyich, Mark A. Jutila and Mark T. Quinn* Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA Epilobium angustifolium is a medicinal plant used around the world in traditional medicine for the treatment of many disorders and ailments. Experimental studies have demonstrated that Epilobium extracts possess a broad range of pharmacological and therapeutic effects, including antioxidant, anti-proliferative, anti-inflammatory, an- tibacterial, and anti-aging properties. Flavonoids and ellagitannins, such as oenothein B, are among the com- pounds considered to be the primary biologically active components in Epilobium extracts. In this review, we focus on the biological properties and the potential clinical usefulness of oenothein B, flavonoids, and other poly- phenols derived from E. angustifolium. Understanding the biochemical properties and therapeutic effects of polyphenols present in E.
    [Show full text]
  • 1 Alkaloid Drugs
    1 Alkaloid Drugs Most plant alkaloids are derivatives of tertiary amines, while others contain primary, secondary or quarternary nitrogen. The basicity of individual alkaloids varies consider- ably, depending on which of the four types is represented. The pK, values (dissociation constants) lie in the range of 10-12 for very weak bases (e.g. purines), of 7-10 for weak bases (e.g. Cinchona alkaloids) and of 3-7 for medium-strength bases (e.g. Opium alkaloids). 1.1 Preparation of Extracts Alkaloid drugs with medium to high alkaloid contents (31%) Powdered drug (Lg) is mixed thoroughly with Iml 10Yo ammonia solution or 10% General method, Na,CO, solution and then extracted for lOmin with 5ml methanol under reflux. The extraction filtrate is then concentrated according to the total alltaloids of the specific drug, so that method A 100p1 contains 50-100pg total alkaloids (see drug list, section 1.4). Rarmalae semen: Powdered drug (Ig) is extracted with lOml methanol for 30min Exception under reflux. The filtrate is diluted 1:10 with methanol and 20pl is used for TLC. Strychni semen: Powdered seeds (Ig) are defatted with 20 rnl n-hexane for 30min under reflux. The defatted seeds are then extracted with lOml methanol for lOmin under reflux. A total of 30yl of the filtrate is used for TL.C. Colchici semen: Powdered seeds (1 g) are defatted with 20 ml n-hexane for 30 min under reflux. The defiitted seeds are then extracted for 15 min with 10ml chloroform. After this, 0.4ml 10% NH, is added to the mixture, shaken vigorously and allowed to stand for about 30min before fillration.
    [Show full text]
  • WO 2018/002916 Al O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/002916 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C08F2/32 (2006.01) C08J 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C08G 18/08 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/IL20 17/050706 HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (22) International Filing Date: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 26 June 2017 (26.06.2017) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 246468 26 June 2016 (26.06.2016) IL kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: TECHNION RESEARCH & DEVEL¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, OPMENT FOUNDATION LIMITED [IL/IL]; Senate TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, House, Technion City, 3200004 Haifa (IL).
    [Show full text]
  • Hyperici Herba (Pharm
    30 January 2018 EMA/HMPC/244315/2016 Committee on Herbal Medicinal Products (HMPC) Assessment report on Hypericum perforatum L., herba Draft Based on Article 10a of Directive 2001/83/EC as amended (well-established use) Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use) Herbal substance(s) (binomial scientific Hypericum perforatum L., herba name of the plant, including plant part) Herbal preparation(s) Traditional use a) Dry extract (DER 4-7:1), extraction solvent ethanol 38% (m/m) = 45% V/V b) Liquid extract (DER 1:4-20), extraction solvent vegetable oil c) Liquid extract (DER 1:13), extraction solvent maize oil or other suitable vegetable oil d) Tincture (ratio herbal substance : extraction solvent 1:10), extraction solvent ethanol 45-50% (V/V) e) Liquid extract (DER 1:2-7), extraction solvent ethanol 50% (V/V) f) Expressed juice from the fresh herb (DER 1:0.5-0.9) g) Comminuted herbal substance h) Powdered herbal substance Well-established use a) Dry extract (DER 3-7:1), extraction solvent methanol (80% V/V) b) Dry extract (DER 3-6:1), extraction solvent ethanol (80% V/V) 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. c) Dry extract (DER 2.5-8:1), extraction solvent ethanol (50-68% V/V) Pharmaceutical form(s) Comminuted herbal substance as herbal tea for oral use.
    [Show full text]
  • Quercetin-3-O-Glucuronide in the Ethanol Extract of Lotus Leaf (Nelumbo Nucifera) Enhances Sleep Quantity and Quality in a Rodent Model Via a Gabaergic Mechanism
    molecules Article Quercetin-3-O-glucuronide in the Ethanol Extract of Lotus Leaf (Nelumbo nucifera) Enhances Sleep Quantity and Quality in a Rodent Model via a GABAergic Mechanism Singeun Kim 1, Ki-Bae Hong 2 , Kyungae Jo 1,* and Hyung Joo Suh 1,3,* 1 Department of Integrated Biomedical and Life Sciences, Graduate School, Korea University, Seoul 02841, Korea; [email protected] 2 Department of Food Science and Nutrition, Jeju National University, Jeju 63243, Korea; [email protected] 3 Transdisciplinary Major in Learning Health Systems, Department of Healthcare Sciences, Graduate School, Korea University, Seoul 02841, Korea * Correspondence: [email protected] (K.J.); [email protected] (H.J.S.); Tel.: +82-2-940-2764 (H.J.S.) Abstract: Current pharmacological treatments for insomnia carry several and long-term side effects. Therefore, natural products without side effects are warranted. In this study, the sleep-promoting activity of the lotus leaf (Nelumbo nucifera) extract was assessed using ICR mice and Sprague Dawley rats. A pentobarbital-induced sleep test and electroencephalogram analysis were conducted to measure sleep latency time, duration, and sleep architecture. The action mechanism of the extract was evaluated through ligand binding experiments. A high dose (300 mg/kg) of the ethanolic lotus leaf extract significantly increased sleep duration compared to the normal group (p < 0.01). Administration of low (150 mg/kg) and high doses (300 mg/kg) of the extract significantly increased Citation: Kim, S.; Hong, K.-B.; Jo, K.; sleep quality, especially the relative power of theta waves (p < 0.05), compared to the normal Suh, H.J.
    [Show full text]
  • Quercetin As a Natural Therapeutic Candidate for the Treatment of Influenza Virus
    biomolecules Review Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus Parvaneh Mehrbod 1,* , Dorota Hudy 2 , Divine Shyntum 3 , Jarosław Markowski 2, Marek J. Łos 4 and Saeid Ghavami 5 1 Influenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran 1316943551, Iran 2 Department of Laryngology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-027 Katowice, Poland; [email protected] (D.H.); [email protected] (J.M.) 3 Biotechnology Center, Silesian University of Technology, 44-100 Gliwice, Poland; [email protected] 4 Department of Pathology, Pomeranian Medical University, 71-344 Szczecin, Poland; [email protected] 5 Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; [email protected] * Correspondence: [email protected]; Tel.: +98-21-66953311-15 Abstract: The medical burden caused by respiratory manifestations of influenza virus (IV) outbreak as an infectious respiratory disease is so great that governments in both developed and develop- ing countries have allocated significant national budget toward the development of strategies for prevention, control, and treatment of this infection, which is seemingly common and treatable, but can be deadly. Frequent mutations in its genome structure often result in resistance to standard medications. Thus, new generations of treatments are critical to combat this ever-evolving infection. Plant materials and active compounds have been tested for many years, including, more recently, active compounds like flavonoids. Quercetin is a compound belonging to the flavonols class and has shown therapeutic effects against influenza virus.
    [Show full text]
  • Reference Substances 2018/2019
    Reference Substances 2018 / 2019 Reference Substances Reference 2018/2019 Contents | 3 Contents Page Welcome 4 Our Services 5 Reference Substances 6 Index I: Alphabetical List of Reference Substances and Synonyms 156 Index II: Plant-specific Marker Compounds 176 Index III: CAS Registry Numbers 214 Index IV: Substance Classification 224 Our Reference Substance Team 234 Order Information 237 Order Form 238 Prices insert 4 | Welcome Welcome to our new 2018 / 2019 catalogue! PhytoLab proudly presents the new you will also be able to view exemplary Index I contains an alphabetical list of all 2018 / 2019 catalogue of phyproof® certificates of analysis and download substances and their synonyms. It pro- Reference Substances. The seventh edition material safety data sheets (MSDS). vides information which name of a refer- of our catalogue now contains well over ence substance is used in this catalogue 1300 phytochemicals. As part of our We very much hope that our product and guides you directly to the correct mission to be your leading supplier of portfolio meets your expectations. The list page. herbal reference substances PhytoLab of substances will be expanded even has characterized them as primary further in the future, based upon current If you are a planning to analyse a specific reference substances and will supply regulatory requirements and new scientific plant please look for the botanical them together with the comprehensive developments. The most recent information name in Index II. It will inform you about certificates of analysis you are familiar will always be available on our web site. common marker compounds for this herb. with.
    [Show full text]